Modulation of infection by gamma interferon treatment following trauma
- PMID: 3137168
- PMCID: PMC259581
- DOI: 10.1128/iai.56.9.2412-2416.1988
Modulation of infection by gamma interferon treatment following trauma
Abstract
Gamma interferon (IFN-gamma) has been shown to be able to modulate several microbiol infections, perhaps as a result of the immunoregulatory properties of this interferon. The present study was designed to determine the efficacy of IFN-gamma treatment in a mouse model of infection that simulates clinical conditions occurring following abdominal trauma. In this model, mice were first infected intraperitoneally with Escherichia coli and then underwent immediate surgical laparotomy. Finally the mice were secondarily infected intramuscularly with Klebsiella pneumoniae. Groups of CBA/J mice received either IFN-gamma or RPMI 1640 medium (controls) subcutaneously. IFN-gamma was administered daily at a dose of 7,500 U, commencing 1 h postlaparotomy and continuing until the second bacterial challenge. Mice treated with IFN-gamma survived significantly longer than controls. The Ia antigen expression of peripheral blood monocytes was severely reduced in animals for 3 days after laparotomy and for 5 days after laparotomy and infection. This drop in Ia antigen expression was prevented in animals treated with IFN-gamma. These data indicate that IFN-gamma had a beneficial effect in a model simulating bacterial infection after trauma and that maintenance of Ia antigen expression in interferon-treated mice may have contributed to the observed therapeutic effect.
Similar articles
-
Effect of interferon-gamma treatment on the course of a burn wound infection.J Interferon Res. 1988 Jun;8(3):367-73. doi: 10.1089/jir.1988.8.367. J Interferon Res. 1988. PMID: 3137276
-
Modulation of Klebsiella pneumoniae infection of mice by interferon-gamma.Clin Exp Immunol. 1988 Jun;72(3):406-9. Clin Exp Immunol. 1988. PMID: 3139342 Free PMC article.
-
Effects of interferon-gamma treatment on surgically simulated wound infection in mice.Microb Pathog. 1988 Feb;4(2):165-8. doi: 10.1016/0882-4010(88)90058-7. Microb Pathog. 1988. PMID: 3143895
-
Involvement of T cells in enhanced resistance to Klebsiella pneumoniae septicemia in mice treated with liposome-encapsulated muramyl tripeptide phosphatidylethanolamine or gamma interferon.Infect Immun. 1998 May;66(5):1962-7. doi: 10.1128/IAI.66.5.1962-1967.1998. Infect Immun. 1998. PMID: 9573076 Free PMC article.
-
Shunt infections: prevention and treatment.Clin Neurosurg. 1985;32:652-64. Clin Neurosurg. 1985. PMID: 3905157 Review. No abstract available.
Cited by
-
Immune modulation after traumatic brain injury.Front Med (Lausanne). 2022 Dec 1;9:995044. doi: 10.3389/fmed.2022.995044. eCollection 2022. Front Med (Lausanne). 2022. PMID: 36530909 Free PMC article. Review.
-
Physiological and morphological changes in bovine mammary glands following intramammary infusion of recombinant interferon-gamma.Can J Vet Res. 1992 Jan;56(1):22-7. Can J Vet Res. 1992. PMID: 1586890 Free PMC article.
-
Rationale, design and performance of a clinical trial to investigate interferon-gamma (Imukin) in the prophylactic treatment of severe burns-related infections.Intensive Care Med. 1996 Oct;22 Suppl 4:S468-73. doi: 10.1007/BF01743726. Intensive Care Med. 1996. PMID: 8923091
-
Interferon gamma in trauma-related infections.Intensive Care Med. 1996 Oct;22 Suppl 4:S462-7. doi: 10.1007/BF01743725. Intensive Care Med. 1996. PMID: 8923090 Clinical Trial.
-
Inhibition of macrophage-activating cytokines is beneficial in the acute septic response.Ann Surg. 1991 Oct;214(4):502-8; discussion 508-9. doi: 10.1097/00000658-199110000-00014. Ann Surg. 1991. PMID: 1659339 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical